161 related articles for article (PubMed ID: 8542574)
1. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage.
Price BD; Youmell MB
Cancer Res; 1996 Jan; 56(2):246-50. PubMed ID: 8542574
[TBL] [Abstract][Full Text] [Related]
2. Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblasts.
Enns L; Murray D; Mirzayans R
Br J Cancer; 1999 Nov; 81(6):959-65. PubMed ID: 10576651
[TBL] [Abstract][Full Text] [Related]
3. Low dose of wortmannin reduces radiosensitivity of human glioblastoma cells through the p53 pathway.
Okaichi K; Suzuki K; Morita N; Ikeda M; Takahashi H; Matsuda N; Watanabe M; Okumura Y
Oncol Rep; 2002; 9(4):859-62. PubMed ID: 12066222
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the radiosensitizing effect of wortmannin, DNA double-strand break rejoining, and p21WAF1 induction in human normal and tumor-derived cells.
Mirzayans R; Pollock S; Scott A; Enns L; Andrais B; Murray D
Mol Carcinog; 2004 Mar; 39(3):164-72. PubMed ID: 14991746
[TBL] [Abstract][Full Text] [Related]
5. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells.
Tomiyama K; Nakata H; Sasa H; Arimura S; Nishio E; Watanabe Y
Biochem Biophys Res Commun; 1995 Jul; 212(1):263-9. PubMed ID: 7541986
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase inhibitor wortmannin blocks mitogenic activation of the transferrin receptor gene promoter in late G1.
Miskimins WK; King F; Miskimins R
Cell Growth Differ; 1997 May; 8(5):565-70. PubMed ID: 9149907
[TBL] [Abstract][Full Text] [Related]
7. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Powis G; Bonjouklian R; Berggren MM; Gallegos A; Abraham R; Ashendel C; Zalkow L; Matter WF; Dodge J; Grindey G
Cancer Res; 1994 May; 54(9):2419-23. PubMed ID: 8162590
[TBL] [Abstract][Full Text] [Related]
8. Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks.
Chernikova SB; Wells RL; Elkind MM
Radiat Res; 1999 Feb; 151(2):159-66. PubMed ID: 9952300
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
Sarkaria JN; Tibbetts RS; Busby EC; Kennedy AP; Hill DE; Abraham RT
Cancer Res; 1998 Oct; 58(19):4375-82. PubMed ID: 9766667
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs.
Norman BH; Shih C; Toth JE; Ray JE; Dodge JA; Johnson DW; Rutherford PG; Schultz RM; Worzalla JF; Vlahos CJ
J Med Chem; 1996 Mar; 39(5):1106-11. PubMed ID: 8676346
[TBL] [Abstract][Full Text] [Related]
12. Effects of hyperthermia on p53 protein expression and activity.
Guan J; Stavridi E; Leeper DB; Iliakis G
J Cell Physiol; 2002 Mar; 190(3):365-74. PubMed ID: 11857452
[TBL] [Abstract][Full Text] [Related]
13. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity.
Yao R; Cooper GM
Oncogene; 1996 Jul; 13(2):343-51. PubMed ID: 8710373
[TBL] [Abstract][Full Text] [Related]
14. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.
Schultz RM; Merriman RL; Andis SL; Bonjouklian R; Grindey GB; Rutherford PG; Gallegos A; Massey K; Powis G
Anticancer Res; 1995; 15(4):1135-9. PubMed ID: 7653991
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
[TBL] [Abstract][Full Text] [Related]
18. p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents.
Grombacher T; Eichhorn U; Kaina B
Oncogene; 1998 Aug; 17(7):845-51. PubMed ID: 9780001
[TBL] [Abstract][Full Text] [Related]
19. Growth-inhibitory effect of phosphatidylinositol 3-kinase inhibitor on human pancreatic cancer cells and expression of Bcl-2 family.
Katayose K; Seki T; Ohba N; Funatomi H; Goto N; Mitamura K
Anticancer Res; 2003; 23(3B):2383-7. PubMed ID: 12894518
[TBL] [Abstract][Full Text] [Related]
20. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells.
Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
Radiat Med; 2003; 21(3):120-7. PubMed ID: 12868860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
